Harrow, Inc. Amortization
Harrow, Inc. (HROW) reported Amortization of $2.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2022-05-05
- Harrow, Inc. amortization for the quarter ending 2022-03-31 was $2.00K, a 0.00% change year-over-year.
- Harrow, Inc. amortization for the quarter ending 2021-03-31 was $2.00K, a 95.56% decline year-over-year.
- Harrow, Inc. amortization for the quarter ending 2020-03-31 was $45.00K, a 31.82% decline year-over-year.
- Harrow, Inc. amortization for the quarter ending 2019-12-31 was $44.00K.
- Harrow, Inc. amortization for fiscal 2021 was $8.00K, a 0.00% change from fiscal 2020.
- Harrow, Inc. amortization for fiscal 2020 was $8.00K, a 96.17% decline from fiscal 2019.
- Harrow, Inc. amortization for fiscal 2019 was $209.00K.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month | Amortization 12 month |
|---|---|---|---|---|
| 2022-03-31 | $2.00K 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | $8.00K 10-K · filed 2022-03-10 | |||
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $8.00K 10-K · filed 2022-03-10 | |||
| 2020-03-31 | $45.00K 10-Q · filed 2020-05-11 | $89.00K derived: sum of 2 quarters · filed 2020-05-11 | $129.00K derived: sum of 3 quarters · filed 2020-05-11 | $188.00K derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $84.00K derived: sum of 2 quarters · filed 2020-03-13 | $143.00K derived: sum of 3 quarters · filed 2020-03-13 | $209.00K 10-K · filed 2020-03-13 |
| 2019-09-30 | $40.00K 10-Q · filed 2019-11-13 | $99.00K derived: sum of 2 quarters · filed 2019-11-13 | $165.00K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $59.00K 10-Q · filed 2019-08-14 | $125.00K 10-Q · filed 2019-08-14 | ||
| 2019-03-31 | $66.00K 10-Q · filed 2020-05-11 | |||
| 2014-06-30 | $17.43K 10-Q · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |